Simultaneous tubular excretion and reabsorption of pindolol in man
- 1 January 1981
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 21 (1) , 65-72
- https://doi.org/10.1007/bf00609590
Abstract
The plasma concentrations of pindolol have been examined following the administration of single doses of 15 mg tablets to eight healthy male subjects. The apparent half-life of elimination in plasma (t1/2=4.05 h) and in urine (t1/2=3.21 h) was calculated using conventional pharmacokinetic methods. The renal clearance was estimated by plotting urinary excretion rates versus plasma concentrations; for all subjects these plots were curved. In addition to these graphical estimations, the plasma concentrations of pindolol and the urinary excretion data for each volunteer were simultaneously fitted using a one or two-compartment open body model; a computer program using non-linear regression algorithms was used. This procedure did not give an adequate fit to the data. Another type of data analysis, using a population — based model, permitted us to show that the renal elimination of pindolol in man comprises of two separate processes — tubular secretion and reabsorption, which was partially saturable under the experimental conditions. The theoretical relevance and clinical significance of these findings are discussed.Keywords
This publication has 5 references indexed in Scilit:
- Compartmental analysis—I: LINDE, a program using an analytical method of integration with constituent matricesComputers in Biology and Medicine, 1979
- PHARMACOKINETICS AND CLEARANCES RELATED TO RENAL PROCESSES1978
- Single and multiple dose pharmacokinetics of pindololEuropean Journal of Clinical Pharmacology, 1978
- A method for the fluorimetric determination of 4-(2-Hydroxy-3-isopropylaminopropoxy)-indole (LB 46), aβ-blocking agent, in plasma and urineCellular and Molecular Life Sciences, 1969